ALRTF
ALR Technologies SG Ltd.
Price Chart
Latest Quote
$0.02
Current Price| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.02 |
| Day Low | $0.01 |
| Volume | 21,199 |
Stock Information
| Shares Outstanding | 645.47M |
| Total Debt | $30.24M |
| Cash Equivalents | $2K |
| Net Income | $-20.62M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $11.62M |
| EPS (TTM) | $-0.04 |
| Exchange | PNK |
đ Custom Metrics & Score
Score: 8/42| Debt to Equity | -0.79 |
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Avg Revenue Growth | -25.00% |
| Return on Equity | 43.83% |
| Avg FCF Growth | -7.70% |
| FCF Yield | -13.25% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.01 | 121,297 |
| 2026-01-30 | $0.01 | 20,000 |
| 2026-01-29 | $0.01 | 1,028,450 |
| 2026-01-28 | $0.02 | 0 |
| 2026-01-27 | $0.02 | 10,250 |
| 2026-01-26 | $0.02 | 38,678 |
| 2026-01-23 | $0.02 | 2,105 |
| 2026-01-22 | $0.02 | 200 |
| 2026-01-21 | $0.02 | 19,350 |
| 2026-01-20 | $0.02 | 104,229 |
| 2026-01-16 | $0.02 | 15,300 |
| 2026-01-15 | $0.02 | 35,000 |
| 2026-01-14 | $0.02 | 0 |
| 2026-01-13 | $0.02 | 49,952 |
| 2026-01-12 | $0.02 | 40,000 |
| 2026-01-09 | $0.02 | 11,725 |
| 2026-01-08 | $0.02 | 0 |
| 2026-01-07 | $0.02 | 11,004 |
| 2026-01-06 | $0.02 | 80,000 |
| 2026-01-05 | $0.02 | 125,825 |
About ALR Technologies SG Ltd.
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions for human and animal health diabetes. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.
đ° Latest News
No news articles available at the moment. Check back later for updates on ALRTF.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $0 | $22,096 | $1,176 | $2,523 |
| Cost Of Revenue | $0 | $22,096 | $1,176 | $2,523 |
| Total Revenue | $0 | $25,536 | $2,367 | $7,468 |
| Operating Revenue | $0 | $25,536 | $2,367 | $7,468 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $12,424,430 | $2,521,543 | $6,350,401 | $5,468,328 |
| Total Expenses | $3,499,866 | $4,800,404 | $4,212,317 | $2,913,519 |
| Rent Expense Supplemental | $19,000 | $47,000 | $44,000 | $25,000 |
| Other Income Expense | $46,900 | $-179,000 | $-59,000 | $-68,614 |
| Net Non Operating Interest Income Expense | $-12,424,430 | $-2,521,543 | $-6,350,401 | $-5,468,328 |
| Interest Expense Non Operating | $12,424,430 | $2,521,543 | $6,350,401 | $5,468,328 |
| Operating Expense | $3,499,866 | $4,778,308 | $4,211,141 | $2,910,996 |
| General And Administrative Expense | $2,616,000 | $3,374,000 | $3,729,000 | $2,412,000 |
| Selling And Marketing Expense | - | - | - | $132,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-15,877,514 | $-7,474,514 | $-10,618,809 | $-8,443,315 |
| Net Interest Income | $-12,424,430 | $-2,521,543 | $-6,350,401 | $-5,468,328 |
| Normalized Income | $-15,924,414 | $-7,295,514 | $-10,559,809 | $-8,374,701 |
| Net Income From Continuing And Discontinued Operation | $-15,877,514 | $-7,474,514 | $-10,618,809 | $-8,443,315 |
| Net Income Common Stockholders | $-15,877,514 | $-7,474,514 | $-10,618,809 | $-8,443,315 |
| Net Income | $-15,877,514 | $-7,474,514 | $-10,618,809 | $-8,443,315 |
| Net Income Including Noncontrolling Interests | $-15,877,396 | $-7,475,411 | $-10,619,351 | $-8,442,993 |
| Net Income Continuous Operations | $-15,877,396 | $-7,475,411 | $-10,619,351 | $-8,442,993 |
| Pretax Income | $-15,877,396 | $-7,475,411 | $-10,619,351 | $-8,442,993 |
| Special Income Charges | $-41,100 | $-139,000 | $0 | $-33,614 |
| Operating Income | $-3,499,866 | $-4,774,868 | $-4,209,950 | $-2,906,051 |
| Gross Profit | $0 | $3,440 | $1,191 | $4,945 |
| Total Operating Income As Reported | - | $-4,813,971 | $-4,269,599 | $-2,941,373 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-0.03 | $-0.01 | $-0.02 | $-0.02 |
| Basic EPS | $-0.03 | $-0.01 | $-0.02 | $-0.02 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,499,866 | $-4,774,868 | $-4,209,950 | $-2,906,051 |
| Total Unusual Items | $46,900 | $-179,000 | $-59,000 | $-68,614 |
| Total Unusual Items Excluding Goodwill | $46,900 | $-179,000 | $-59,000 | $-68,614 |
| EBITDA (Bullshit earnings) | $-3,452,966 | $-4,953,868 | $-4,268,950 | $-2,974,665 |
| EBIT | $-3,452,966 | $-4,953,868 | $-4,268,950 | $-2,974,665 |
| Diluted Average Shares | $598,924,378 | $581,016,295 | $548,078,686 | $534,980,347 |
| Basic Average Shares | $598,924,378 | $581,016,295 | $548,078,686 | $534,980,347 |
| Diluted NI Availto Com Stockholders | $-15,877,514 | $-7,474,514 | $-10,618,809 | $-8,443,315 |
| Other Special Charges | $41,100 | $139,000 | - | $33,614 |
| Write Off | $41,100 | $0 | $0 | - |
| Gain On Sale Of Security | $88,000 | $-40,000 | $-59,000 | $-35,000 |
| Research And Development | $883,866 | $1,404,308 | $482,141 | $498,996 |
| Selling General And Administration | $2,616,000 | $3,374,000 | $3,729,000 | $2,412,000 |
| Other Gand A | $375,000 | $657,000 | $1,114,000 | $886,000 |
| Rent And Landing Fees | $19,000 | $47,000 | $44,000 | $25,000 |
| Salaries And Wages | $2,222,000 | $2,670,000 | $2,571,000 | $1,501,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-36,223,719 | $-31,916,155 | $-28,554,785 | $-24,312,143 |
| Total Assets | $79,472 | $155,198 | $377,289 | $193,217 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $79,472 | $155,198 | $377,289 | $193,217 |
| Prepaid Assets | $27,952 | $44,016 | $228,661 | $77,295 |
| Inventory | $10,863 | $11,000 | $0 | - |
| Receivables | $0 | $41,100 | $0 | - |
| Accounts Receivable | $0 | $41,100 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $40,657 | $59,082 | $148,628 | $115,922 |
| Cash And Cash Equivalents | $40,657 | $59,082 | $148,628 | $115,922 |
| Cash Financial | $40,657 | $59,082 | $148,628 | $115,922 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $28,581,882 | $25,340,800 | $22,777,843 | $19,148,245 |
| Total Debt | $28,622,539 | $25,399,882 | $22,926,471 | $19,264,167 |
| Current Debt And Capital Lease Obligation | $28,622,539 | $25,399,882 | $21,083,489 | $17,321,711 |
| Current Debt | $28,622,539 | $25,399,882 | $21,083,489 | $17,321,711 |
| Other Current Borrowings | $22,550,625 | $20,415,460 | $15,828,155 | $14,279,745 |
| Long Term Debt And Capital Lease Obligation | - | - | $1,842,982 | $1,942,456 |
| Long Term Debt | - | - | $1,842,982 | $1,942,456 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $36,303,191 | $32,071,353 | $28,932,074 | $24,505,360 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $1,842,982 | $1,942,456 |
| Current Liabilities | $36,303,191 | $32,071,353 | $27,089,092 | $22,562,904 |
| Current Notes Payable | $6,071,914 | $4,984,422 | $5,255,334 | $3,041,966 |
| Payables And Accrued Expenses | $7,680,652 | $6,671,471 | $6,005,603 | $5,238,793 |
| Interest Payable | $5,701,679 | $5,170,149 | $4,662,731 | $4,110,647 |
| Payables | $1,678,839 | $1,183,037 | $1,054,285 | $806,059 |
| Accounts Payable | $1,678,839 | $1,183,037 | $1,054,285 | $806,059 |
| Current Deferred Liabilities | - | $2,905 | $0 | $2,400 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $-36,223,719 | $-31,916,155 | $-28,554,785 | $-24,312,143 |
| Total Equity Gross Minority Interest | $-36,223,719 | $-31,916,155 | $-28,554,785 | $-24,312,143 |
| Stockholders Equity | $-36,223,719 | $-31,916,155 | $-28,554,785 | $-24,312,143 |
| Gains Losses Not Affecting Retained Earnings | $-844 | $-844 | $6,147 | $-11,409 |
| Retained Earnings | $-135,985,914 | $-120,108,400 | $-112,633,886 | $-102,015,077 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $635,466,844 | $632,466,844 | $551,966,844 | $542,716,344 |
| Share Issued | $635,466,844 | $632,466,844 | $551,966,844 | $542,716,344 |
| Tangible Book Value | $-36,223,719 | $-31,916,155 | $-28,554,785 | $-24,312,143 |
| Invested Capital | $-7,601,180 | $-6,516,273 | $-5,628,314 | $-5,047,976 |
| Working Capital | $-36,223,719 | $-31,916,155 | $-26,711,803 | $-22,369,687 |
| Total Capitalization | $-36,223,719 | $-31,916,155 | $-26,711,803 | $-22,369,687 |
| Foreign Currency Translation Adjustments | $-844 | $-844 | $6,147 | $-11,409 |
| Additional Paid In Capital | $68,477,402 | $57,280,320 | $56,032,129 | $50,043,543 |
| Capital Stock | $31,285,637 | $30,912,769 | $28,040,825 | $27,670,800 |
| Common Stock | $31,285,637 | $30,912,769 | $28,040,825 | $27,670,800 |
| Current Accrued Expenses | $6,001,813 | $5,488,434 | $4,951,318 | $4,432,734 |
| Treasury Shares Number | - | $0 | - | - |
| Current Deferred Revenue | - | $2,905 | $0 | $2,400 |
| Preferred Stock | - | - | $0 | $0 |
| Line Of Credit | - | - | - | $14,008,833 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-1,539,756 | $-1,621,664 | $-2,573,606 | $-2,224,970 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-1,539,756 | $-1,621,664 | $-2,573,606 | $-2,224,970 |
| Cash Flow From Continuing Operating Activities | $-1,539,756 | $-1,621,664 | $-2,573,606 | $-2,224,970 |
| Operating Gains Losses | $-74,458 | $174,827 | - | $33,614 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $0 | $744,655 | $25 | $1,136,832 |
| Financing Cash Flow | $1,521,331 | $1,539,109 | $2,507,261 | $2,286,111 |
| Cash Flow From Continuing Financing Activities | $1,521,331 | $1,539,109 | $2,507,261 | $2,286,111 |
| Net Common Stock Issuance | $0 | $744,655 | $25 | $1,136,832 |
| Common Stock Issuance | $0 | $744,655 | $25 | $1,136,832 |
| Cash Dividends Paid | - | - | $0 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $0 | $0 | $-649,708 | $0 |
| Issuance Of Debt | $1,515,331 | $794,454 | $3,156,944 | $1,149,279 |
| End Cash Position | $40,657 | $59,082 | $148,628 | $115,922 |
| Beginning Cash Position | $59,082 | $148,628 | $115,922 | $66,190 |
| Effect Of Exchange Rate Changes | $0 | $-6,991 | $99,051 | $-11,409 |
| Changes In Cash | $-18,425 | $-82,555 | $-66,345 | $61,141 |
| Proceeds From Stock Option Exercised | $6,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $1,515,331 | $794,454 | $2,507,236 | $1,149,279 |
| Net Short Term Debt Issuance | $1,515,331 | $794,454 | $727,986 | $1,149,279 |
| Short Term Debt Payments | $0 | $0 | $-649,708 | $0 |
| Short Term Debt Issuance | $1,515,331 | $794,454 | $1,377,694 | $1,149,279 |
| Net Long Term Debt Issuance | $0 | $0 | $1,779,250 | $0 |
| Long Term Debt Issuance | $0 | $0 | $1,779,250 | $0 |
| Interest Paid Cfo | $-257,666 | $-310,603 | $-496,081 | - |
| Change In Working Capital | $1,025,382 | $1,133,413 | $728,794 | $723,712 |
| Change In Payables And Accrued Expense | $1,009,181 | $983,868 | $880,160 | $738,348 |
| Change In Accrued Expense | $531,530 | $531,418 | $542,834 | $527,336 |
| Change In Interest Payable | $531,530 | $531,418 | $542,834 | $527,336 |
| Change In Payable | $477,651 | $452,450 | $337,326 | $211,012 |
| Change In Account Payable | $477,651 | $452,450 | $337,326 | $211,012 |
| Change In Prepaid Assets | $16,064 | $201,645 | $-151,366 | $-14,636 |
| Change In Inventory | $137 | $-11,000 | $0 | $0 |
| Change In Receivables | $0 | $-41,100 | $0 | $0 |
| Changes In Account Receivables | $0 | $-41,100 | $0 | $0 |
| Other Non Cash Items | $2,071,960 | $1,988,164 | $2,042,310 | $1,057,801 |
| Stock Based Compensation | $11,531,440 | $2,867,049 | $5,770,180 | $4,403,218 |
| Asset Impairment Charge | $41,100 | $0 | $0 | - |
| Net Foreign Currency Exchange Gain Loss | $-74,458 | $35,827 | $0 | $0 |
| Net Income From Continuing Operations | $-15,877,514 | $-7,474,514 | $-10,618,809 | $-8,443,315 |
| Interest Paid Cff | - | - | $-496,081 | $-456,725 |